General Information of the Compound
| Compound ID |
CP0380658
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
2-(2-Bromoanilino)-1H-imidazole
BDBM50055833
CHEMBL76457
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H8BrN3
|
||||||||||||||||||
| Molecular Weight |
238.088
|
||||||||||||||||||
| Canonical SMILES |
Brc1ccccc1Nc1ncc[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H8BrN3/c10-7-3-1-2-4-8(7)13-9-11-5-6-12-9/h1-6H,(H2,11,12,13)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KHNAVCNEASQADL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01650, Alpha-2A adrenergic receptor
Protein ID: PT03109, Alpha-2B adrenergic receptor
Protein ID: PT01598, Alpha-2C adrenergic receptor
Clinical Information about the Compound
Drug 1 ( (2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine )
| Drug Name | (2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine | ||
|---|---|---|---|
| Target(s) | |||